Competing risks of death in patients with localized renal cell carcinoma: A comorbidity based model

Journal of Urology

Volumn 188, Issue 6, 2012, Pages 2077-2083

  Kutikov, Alexander ^a   Egleston, Brian L ^b   Canter, Daniel ^a   Smaldone, Marc C ^a   Wong, Yu Ning ^a   Uzzo, Robert G ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TEMPLE UNIVERSITY   (United States)

Author keywords

carcinoma; kidney; mortality; nomograms; renal cell; risk

Indexed keywords

AGE; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER PATIENT; CANCER SIZE; CANCER SURVIVAL; CAUSE OF DEATH; CHARLSON COMORBIDITY INDEX SCORE; CLEAR CELL CARCINOMA; COMORBIDITY; CORRELATIONAL STUDY; FEMALE; FOLLOW UP; GENDER; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; OVERALL SURVIVAL; PAPILLARY CARCINOMA; PATIENT COUNSELING; PREDICTION; PRIORITY JOURNAL; PROBABILITY; PROGNOSIS; RACE; RISK ASSESSMENT; SCORING SYSTEM; STATISTICAL MODEL;

AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; CAUSE OF DEATH; COMORBIDITY; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY NEOPLASMS; MALE; MODELS, STATISTICAL; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE;

EID: 84869091288     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2012.07.100     Document Type: Article

References (30)

1. H.G. Welch, W.C. Black Overdiagnosis in cancer J Natl Cancer Inst 102 2010 605
2. A. Fagerlin, B.J. Zikmund-Fisher, P.A. Ubel Cure me even if it kills me: preferences for invasive cancer treatment Med Decis Making 25 2005 614
3. C.D. Mullins, R. Montgomery, S. Tunis Uncertainty in assessing value of oncology treatments Oncologist 15 suppl. 2010 58
4. J.M. Hollingsworth, D.C. Miller, S. Daignault Rising incidence of small renal masses: a need to reassess treatment effect J Natl Cancer Inst 98 2006 1331
5. J. Lagro, R.J. Melis, M.G.M. Olde Rikkert Importance of comorbidity in competing risks analysis in patients with localized renal cell carcinoma J Clin Oncol 28 2010 e298
6. M.C. Smaldone, A. Kutikov, B.L. Egleston Small renal masses progressing to metastases under active surveillance: a systematic review and pooled analysis Cancer 1184 2012 997
7. M.E. Charlson, P. Pompei, K.L. Ales A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 1987 373
8. C.N. Klabunde, A.L. Potosky, J.M. Legler Development of a comorbidity index using physician claims data J Clin Epidemiol 53 2000 1258
9. P.S. Romano, L.L. Roos, J.G. Jollis Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives J Clin Epidemiol 46 1993 1075
10. Calculation of Comorbidity Weights 2011 National Cancer Institute, SEER-Medicare Bethesda
11. J.P. Fine, R.J. Gray A proportional hazards model for the subdistribution of a competing risk J Am Stat Ass 94 1999 496
12. F.E. Harrell General aspects of fitting regression models Regression Modeling Strategies 2001 Springer-Verlag New York
13. M.W. Kattan, G. Heller, M.F. Brennan A competing-risks nomogram for sarcoma-specific death following local recurrence Stat Med 22 2003 3515
14. A. Kutikov, B.L. Egleston, Y.N. Wong Evaluating overall survival and competing risks of death in patients with localized renal cell carcinoma using a comprehensive nomogram J Clin Oncol 28 2010 311
15. L. Lee, W.Y. Cheung, E. Atkinson Impact of comorbidity on chemotherapy use and outcomes in solid tumors: a systematic review J Clin Oncol 29 2011 106
16. G. Lughezzani, M. Sun, S.F. Shariat A population-based competing-risks analysis of the survival of patients treated with radical cystectomy for bladder cancer Cancer 117 2011 103
17. B.E. Kiely, M.H. Tattersall, M.R. Stockler Certain death in uncertain time: informing hope by quantifying a best case scenario J Clin Oncol 28 2010 2802
18. P.C. Albertsen, D.F. Moore, W. Shih Impact of comorbidity on survival among men with localized prostate cancer J Clin Oncol 29 2011 1335
19. T.J. Daskivich, K. Chamie, L. Kwan Comorbidity and competing risks for mortality in men with prostate cancer Cancer 117 2011 4642
20. Kutikov A, Cooperberg MR, Paciorek AT, et al. Evaluating prostate cancer mortality and competing risks of death in patients with localized prostate cancer using a comprehensive nomogram prostate cancer and prostatic diseases. Prostate Cancer Prostatic Dis, Epub ahead of print June 19, 2012.
21. H. Van Poppel, L. Da Pozzo, W. Albrecht A prospective randomized EORTC intergroup phase 3 study comparing the complications of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma Eur Urol 51 2007 1606
22. B.R. Lane, R. Abouassaly, T. Gao Active treatment of localized renal tumors may not impact overall survival in patients aged 75 years or older Cancer 116 2010 3119
23. J.M. Hollingsworth, D.C. Miller, S. Daignault Five-year survival after surgical treatment for kidney cancer: a population-based competing risk analysis Cancer 109 2007 1763
24. J.R. Wilson, M.G. Clarke, P. Ewings The assessment of patient life-expectancy: how accurate are urologists and oncologists? BJU Int 95 2005 794
25. E.B. Lamont, N.A. Christakis Complexities in prognostication in advanced cancer: "to help them live their lives the way they want to." JAMA 290 2003 98
26. G. Lughezzani, M. Sun, L. Budäus Population-based external validation of a competing-risks nomogram for patients with localized renal cell carcinoma J Clin Oncol 28 2010 e299
27. A. Jemal, R. Siegel, J. Xu Cancer statistics, 2010 CA Cancer J Clin 60 2010 277
28. R. Yancik, R.J. Havlik, M.N. Wesley Cancer and comorbidity in older patients: a descriptive profile Ann Epidemiol 6 1996 399
29. J.E. Zeber, L.A. Copeland, B.J. Hosek Cancer rates, medical comorbidities, and treatment modalities in the oldest patients Crit Rev Oncol Hematol 67 2008 237
30. C.N. Klabunde, L.C. Harlan, J.L. Warren Data sources for measuring comorbidity: a comparison of hospital records and Medicare claims for cancer patients Med Care 44 2006 921